Skip to main content

Table 3 Adverse events

From: Randomized clinical trial of low dose suramin intravenous infusions for treatment of autism spectrum disorder

Preferred Term

Placebo N = 18

10 mg/kg N = 15

20 mg/kg N = 19

Total N = 52

Any AE n (%)

11 (61)

9 (60)

16 (84)

36 (69)

Rasha

5

1

8

14

Upper respiratory tract infection

4

3

3

10

Decreased white blood cell countb

4

1

3

8

Vomiting

1

0

6

7

Aggression

0

3

2

5

Pyrexia

2

1

3

6

Constipation

1

1

1

3

Decreased appetite

1

1

1

3

  1. aIncluding several similar terms such as rash, macular rash, and maculopapular rash
  2. bincluding several similar terms such as leukopenia, lymphopenia, and neutropenia